Search

5 result(s) for 'author#Peter Wutzler' within BMC

1. Stroke prevention in patients with acute ischemic stroke and atrial fibrillation in Germany - a cross sectional survey

   Atrial fibrillation (AF) is present in 15–20% of patients with acute ischemic stroke. Oral anticoagulation reduces the risk of AF-related recurrent stroke but clinical guideline recommendations are rather vagu...

   Authors: Alexander Wutzler, Christos Krogias, Anna Grau, Roland Veltkamp, Peter U. Heuschmann and Karl Georg Haeusler

   Citation: BMC Neurology 2019 19:25

   Content type: Research article Published on: 12 February 2019

   • View Full Text
   • View PDF

2. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?

   There is agreement that the infectivity assay with the duck hepatitis B virus (DHBV) is a suitable surrogate test to validate disinfectants for hepatitis B virucidal activity. However, since this test is not w...

   Authors: Andreas Sauerbrei, Michael Schacke, Brigitte Glück, Uwe Bust, Holger F Rabenau and Peter Wutzler

   Citation: BMC Infectious Diseases 2012 12:276

   Content type: Research article Published on: 30 October 2012

   • View Full Text
   • View PDF

3. Varicella vaccination in Europe – taking the practical approach

   Varicella is a common viral disease affecting almost the entire birth cohort. Although usually self-limiting, some cases of varicella can be serious, with 2 to 6% of cases attending a general practice resultin...

   Authors: Paolo Bonanni, Judith Breuer, Anne Gershon, Michael Gershon, Waleria Hryniewicz, Vana Papaevangelou, Bernard Rentier, Hans Rümke, Catherine Sadzot-Delvaux, Jacques Senterre, Catherine Weil-Olivier and Peter Wutzler

   Citation: BMC Medicine 2009 7:26

   Content type: Review Published on: 28 May 2009

   • View Full Text
   • View PDF

4. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study

   Routine annual influenza vaccination is primarily recommended for all persons aged 60 and above and for people with underlying chronic conditions in Germany. Other countries have already adopted additional chi...

   Authors: Markus A Rose, Oliver Damm, Wolfgang Greiner, Markus Knuf, Peter Wutzler, Johannes G Liese, Hagen Krüger, Ulrich Wahn, Tom Schaberg, Markus Schwehm, Thomas F Kochmann and Martin Eichner

   Citation: BMC Infectious Diseases 2014 14:40

   Content type: Research article Published on: 22 January 2014

   • View Full Text
   • View PDF

5. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting

   A controversy exists about the potential effect of childhood varicella vaccination on Herpes Zoster (HZ) incidence. Mathematical models projected temporary HZ incidence increase after vaccine introduction that...

   Authors: Christophe Sauboin, Katsiaryna Holl, Paolo Bonanni, Anne A. Gershon, Bernd Benninghoff, Stephane Carryn, Margaret A. Burgess and Peter Wutzler

   Citation: BMC Infectious Diseases 2019 19:126

   Content type: Research article Published on: 6 February 2019

   • View Full Text
   • View PDF